It is. My brother-in-law is a director for Bayer. They are responsible for manufacturing drugs for hemophiliacs. The money that goes into the research & development is crazy, then trying to get FDA approval after years & years of studies. Add in the dumping of contaminated batches that's worth millions of $, which happens a few times a year because someone F's up. There is a lot more going on behind the scenes than the public is aware of.So with 20 years to protect the patent, I don't think generic drugs is causing the major issues of recapping R&D, it's just damn expensive to do the R&D and make drugs.